TY - JOUR AU - Landis SH AU - Murray T AU - Bolden S AU - Wingo PA TI - Cancer statistics. JA - CA Cancer J Clin PY - 1999/// VL - 49 SP - 8 EP - 31 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.3322/canjclin.49.1.8 N1 - 10.3322/canjclin.49.1.8 UR - http://dx.doi.org/10.3322/canjclin.49.1.8 ER - TY - JOUR AU - Vercelli M AU - Quaglia A AU - Marani E AU - Parodi S TI - Prostate cancer incidence and mortality trends among elderly and adult Europeans. JA - Crit Rev Oncol Hematol PY - 2000/// VL - 35 SP - 133 EP - 44 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1016/S1040-8428(99)00067-0 N1 - 10.1016/S1040-8428(99)00067-0 UR - http://dx.doi.org/10.1016/S1040-8428(99)00067-0 ER - TY - JOUR AU - Gao HW AU - Li YL AU - Wu S AU - Wang YS AU - Zhang HF AU - Pan YZ, TI - Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen. JA - Asian J Androl PY - /// VL - 7 SP - 159 EP - 63 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1111/j.1745-7262.2005.00029.x N1 - 10.1111/j.1745-7262.2005.00029.x UR - http://dx.doi.org/10.1111/j.1745-7262.2005.00029.x ER - TY - JOUR AU - Galliani G AU - Luzzani F AU - Colombo G AU - Conz A AU - Mistrello L AU - Baroae D, TI - On the mode of action of a new contragestational agent (DL111-IT). JA - Contraception PY - 1986/// VL - 33 SP - 263 EP - 83 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1016/0010-7824(86)90019-3 N1 - 10.1016/0010-7824(86)90019-3 UR - http://dx.doi.org/10.1016/0010-7824(86)90019-3 ER - TY - JOUR AU - Yang B AU - Fang RY TI - Synergistic effects on pregnancy-termination activity of DL111-IT in combination with mifepristone. JA - Acta Pharmacol Sin PY - 1996/// VL - 17 SP - 361 EP - 5 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences ER - TY - JOUR AU - He QJ AU - Yang B AU - Wang WF AU - Wu HH AU - Fang RY TI - Synergistic effects of DL111-IT in combination with mifepristone and misoprostol on termination of early pregnancy in preclinical studies. JA - Contraception PY - 2003/// VL - 68 SP - 289 EP - 95 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1016/S0010-7824(03)00179-3 N1 - 10.1016/S0010-7824(03)00179-3 UR - http://dx.doi.org/10.1016/S0010-7824(03)00179-3 ER - TY - JOUR AU - Yang B AU - Cao L AU - Fang RY AU - Gu ZP TI - Luteolytic effects of DL111-IT in pregnant rats. JA - Eur J Pharmacol PY - 1999/// VL - 380 SP - 145 EP - 52 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1016/S0014-2999(99)00529-4 N1 - 10.1016/S0014-2999(99)00529-4 UR - http://dx.doi.org/10.1016/S0014-2999(99)00529-4 ER - TY - JOUR AU - Han EK AU - Lim JT AU - Arber N AU - Rubin MA AU - Xing WQ AU - Weinstein IB TI - Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. JA - Prostate PY - 1998/// VL - 35 SP - 95 EP - 101 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F N1 - 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F UR - http://dx.doi.org/10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F ER - TY - JOUR AU - Wang L AU - Liu D AU - Ahmed T AU - Chung FL AU - Conaway C AU - Chiao JW TI - Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. JA - Int J Oncol PY - 2004/// VL - 24 SP - 187 EP - 92 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences ER - TY - JOUR AU - Cao MY AU - Lee Y AU - Feng NP AU - Al-Qawasmeh RA AU - Viau S AU - Gu XP, TI - NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo. JA - J Pharmacol Exp Ther PY - 2004/// VL - 308 SP - 538 EP - 46 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1124/jpet.103.059618 N1 - 10.1124/jpet.103.059618 UR - http://dx.doi.org/10.1124/jpet.103.059618 ER - TY - JOUR AU - Maddison LA AU - Sutherland DW AU - Darrios RJ AU - Greenberg NM TI - Conditional deletion of Rb causes early stage prostate cancer. JA - Cancer Res PY - 2004/// VL - 64 SP - 6018 EP - 25 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1158/0008-5472.CAN-03-2509 N1 - 10.1158/0008-5472.CAN-03-2509 UR - http://dx.doi.org/10.1158/0008-5472.CAN-03-2509 ER - TY - JOUR AU - Chen Y AU - Martinez LA AU - LaCava M AU - Coghlan L AU - Conti CJ TI - Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1. JA - Oncogene PY - 1998/// VL - 16 SP - 1913 EP - 20 PB - Asian Journal of Andrology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences M3 - 10.1038/sj.onc.1201719 N1 - 10.1038/sj.onc.1201719 UR - http://dx.doi.org/10.1038/sj.onc.1201719 ER -